On October 12, the selection result of 2024 “quality service institute for medical innovation and commercialization” was officially published at the 4th Health Innovation and Commercialization Management Forum held in Haikou, Hainan Province. The nomination of “quality service institute for medical innovation and commercialization” is a pioneering work launched by the National Engineering Research Center for Individualized Diagnostic and Treatment Technology and Furong Laboratory, collaborating with the China Technology Exchange, the West China Medical Technology Transfer Center, and Peking University Medicine Technology Transfer and Innovation Center, to promote the commercialization of medical findings.

The programs nominated include 2024“high-quality institute for medical device R&D service”, 2024“high-quality agency for pharmaceutical intellectual property”, and 2024“high-quality agency for comprehensive service of medical findings commercialization”, 45 organizations were awarded and participated in the seminar.

GE CHENG & CO.  Ltd has been awarded as 2024 “high-quality agency for pharmaceutical intellectual property”after several rounds of strict evaluation and selection.

October 12th, 2024